Salarius Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)1holders −13
0new positions
13sold out
$0.56avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Salarius Pharmaceuticals Inc. in their 13F filings, down 13 from Q2 2025. 0 opened new positions and 13 sold out. The largest holder was Osaic Holdings, Inc. ($33).
- Company
- Salarius Pharmaceuticals Inc.
- CUSIP
- 79400X404
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 13 | $104K |
All 13F filers, Q2 2025 → Q3 2025: 116,432 shares sold, net −116,432 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 59 | $33 |
"% of holder's portfolio" is SALARIUS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Salarius Pharmaceuticals Inc. the manager owns.